Brokers set high price targets for Starlite Technologies shares amid growing demand for data centers
Read more
Aaj Tak
www.aajtak.in

Brokers set high price targets for Starlite Technologies shares amid growing demand for data centers

Starlite shares have shown significant growth over the past ten months, increasing by approximately eightfold. Analysts believe that due to the rising demand for data processing centers, increased capacity, strong financial performance, and a large order book, the stock price could more than double its current level.

On Thursday, Starlite Technologies shares crossed the lower bound of the 5 percent price corridor, reaching 757 rupees, which lowered the company's market capitalization below 39,000 crore rupees. However, this asset fell by more than 28 percent from its 52-week high of 1,054.45 rupees, recorded on October 7, 2026. Despite this correction, the shares have grown by almost 795 percent from the 52-week low of 84.65 rupees, recorded on January 27, 2026.

Starlite Technologies reported a year-over-year (YoY) increase in net profit of approximately 128 times, reaching 517 crore rupees compared to 4 crore rupees in the same period last year. Operating income grew by 145 percent year-over-year to 2,529 crore rupees, and EBITDA increased fivefold to 846 crore rupees, with a margin of 27.1 percent. The company's order book reached an all-time high of 35,274 crore rupees.

In the second quarter of fiscal year 27 (Q2FY27), Starlite Technologies showed impressive results: revenue, adjusted EBITDA, and net profit (PAT) grew quarter-over-quarter (QoQ) by 32, 69, and 100 percent, respectively. JM Financial noted a very high long-term growth outlook supported by the record order portfolio worth 35,274 crore rupees. This portfolio includes a large hyperscaler order worth $1.2 billion, a landmark AI data center contract worth $1.11 billion, as well as major domestic telecommunication orders.

The company's management maintains a revenue target of 20,000 crore rupees for fiscal year 29 (FY29) but has raised the EBITDA margin target for FY29 to 30 percent. It is expected that this increased target will result in a higher margin in the remainder of Q2FY27 than what was recorded in Q2FY27. JM Financial forecasts that the company will achieve cumulative growth rates of 51.91 percent for revenue, 302 percent for EBITDA, and 302 percent for PAT between FY26 and FY29E, and reaffirmed its 'Buy' recommendation with a target price of 1,020 rupees.

Nevertheless, analysts highlighted several significant risks, including difficulties in sourcing necessary raw materials, sharp declines in capital expenditures by hyperscalers and data centers, trade barriers such as anti-dumping duties and ongoing trade wars, low capital expenditure intensity in the telecommunications sector, and legal and regulatory risks.

Starlite Technologies is well-positioned to leverage strong global demand for data center and hyperscaler infrastructure due to its robust order book, technological capabilities, and expanding capacity. Nirmal Bang Institutional Equities believes that good profit growth is expected due to a strong execution outlook, the growing contribution of the data center and cloud services business, and continuous margin expansion. The firm forecasts that normalized EBITDA margins will be 26.3 percent in FY27E and 30.9 percent in FY29E, corresponding to an EBITDA CAGR of 42 percent and a PAT CAGR of 53 percent during FY27E–FY29E. They maintain their EV/EBITDA valuation multiple at 20 for FY28E/FY29E and reaffirm their 'Buy' recommendation with a revised target price of 1,544 rupees.

Other brokerage firms have set the following targets: Arihant Capital Markets — 1,229 rupees; Nomura — 1,350 rupees; NuVama Institutional Equities — 1,460 rupees; and CLSA set the highest target at 1,644 rupees, suggesting a potential growth of 117 percent.

Similar stories

Investment made by Reha Junjhunwala dropped by 50%: explanation of the reasons
Read more
www.aajtak.in

Investment made by Reha Junjhunwala dropped by 50%: explanation of the reasons

Reha Junjhunwala's investments in stocks fell by 50% on Wednesday. Some trading applications showed a drop of up to 50%, but this decline was not due to a reduction in invested funds, but rather to corporate changes.

The reason for such a sharp drop was the distribution of an exclusive stock bonus (ex-bonus) across all Concord Biotech shares on Wednesday, according to previously announced corporate actions. This decision was linked to the announcement of a bonus issuance for relevant shareholders, which reflected in the sharp decrease in share price.

Concord informed the stock exchange documentation that the company's board of directors, at a meeting held on October 27, 2026, set November 4 as the record date. The purpose of this date is to determine shareholders' right to receive bonus shares at a ratio of 1:1, meaning one bonus share for every fully paid existing share. This condition is subject to regulatory approval.

This means that all relevant Concord Biotech shareholders will receive an additional share for each share they hold on the record date. The total number of shares held by all relevant shareholders will double, but the share price will be adjusted accordingly, which will not change the total invested value.

Concord Biotech shares closed on Tuesday at a price of 1229.90 rupees, and after the bonus share issuance adjustment, they opened on Wednesday at a price of 610 rupees. It is possible that some trading applications displayed the unadjusted price from the previous day, which created the impression of a 50-52% drop on the exchange.

After the split adjustment, Concord Biotech shares initially fell to 595 rupees at the beginning of the session, but on Wednesday, they recovered, rising by 4.8% to 623.65 rupees. Meanwhile, the company's total market capitalization approached 13,000 crore rupees. The shares decreased by 24% compared to the 52-week high reached in August 2026 at 807.03 rupees. Nevertheless, the current price is 26% higher compared to the 52-week low recorded in April 2026 at 493.53 rupees.

Concord Biotech Limited, founded in 1984, is a biopharmaceutical company engaged in research and development in India and is among the country's leading API companies. Concord Biotech shares were first listed in August 2023 when the company raised 1,550.52 crore rupees at a price of 741 rupees per share. Currently, the shares are trading 70% above their adjusted IPO price.

Three discretionary trusts established in honor of the children of the late prominent investor Rakesh Junjhunwala own approximately 2.52 crore shares of the company (or 5.04 crore shares based on post-adjustment), representing a 24.10% stake. The value of this stake is currently estimated at 3,143.10 crore rupees.

Sensex rose by 900 points as the market showed significant growth against the backdrop of the US Federal Reserve's decision
Read more
www.aajtak.in

Sensex rose by 900 points as the market showed significant growth against the backdrop of the US Federal Reserve's decision

The Indian stock market demonstrated impressive growth on Thursday, driven by the US Federal Reserve's decision to keep interest rates unchanged. The shift in market sentiment led to a significant recovery.

After the close of trading, the Sensex index reached 74,151.04, showing a rise of 1.24% (905.01 points), while the Nifty climbed by 238 points or 1.05%, reaching 22,936.75. Out of the top 30 BSE stocks, only four declined, whereas 26 stocks showed growth.

Adani Port shares recorded the largest increase, rising by 5%. Additionally, Kotak Mahindra Bank shares increased by approximately 4%. Power Grid, Bajaj Finance, and Eternal shares also posted gains of over 3%. Over 2% growth was also registered in SBI, Hindustan Unilever, Titan, and NTPC shares.

Thanks to this growth, investors realized good profits. The market capitalization of BSE increased from 472 billion rupees to 477 billion rupees, representing an increase in investor invested value of 500 million rupees for the day.

The Fed's decision was a key factor: the Federal Reserve did not change interest rates on Wednesday and decided to postpone any changes in borrowing costs until the US elections next week, awaiting further inflation data, which it stated remains high.

Foreign investors also contributed. Interim data indicates that FPIs purchased Indian stocks worth 872 million rupees ($91.58 million USD) in the second consecutive session on Wednesday. Meanwhile, they sold stocks worth $3.74 billion in October. Domestic Institutional Investors (DIIs) also became net buyers, investing 643 million rupees during the session.

Alternative Investment Options: How to Earn 200 Thousand on a 500 Thousand Investment
Read more
www.aajtak.in

Alternative Investment Options: How to Earn 200 Thousand on a 500 Thousand Investment

The Indian stock market is experiencing a significant decline. The Sensex index has fallen by more than 1200 points in the last four days, and the Nifty has dropped by approximately 400 points. As a result, investors have incurred losses exceeding 10 trillion rupees. Looking at the annual figure, the situation appears even more alarming: since January of this year, investors have lost over 30 trillion rupees, with the Sensex and Nifty declining by 15 percent.

Consequently, many investors are refraining from investing in the market and are looking for other financial instruments that could provide good returns without high market risks. This article presents three options where funds can be placed to generate profit.

These investment schemes include bank deposits (Bank FD), Post Office savings deposits (Post Office RD), and Post Office fixed deposits (Post Office FD). Next, we examine where the highest return can be obtained when investing 500 thousand rupees.

Investing in Post Office RD

When placing five hundred thousand rupees in a Recurring Deposit, one million rupees must be deposited annually, which is equivalent to a monthly contribution of 8334 rupees. For this deposit, the annual interest rate will be 6.7%. After five years, the total amount will be 5,91,634 rupees, of which the interest income will be 91,634 rupees.

Post Office Fixed Deposit

The Post Office offers the option to invest in a fixed deposit with three different maturity periods. By choosing a five-year term for a fixed deposit, one can receive substantial profits and also benefit from tax incentives. For a five-year deposit, the rate is 7.50% per annum. Thus, by investing five hundred thousand rupees for five years, the total amount will reach 7,24,974 rupees, with an interest income of 2,24,974 rupees.

Interest on Bank Deposit

Most banks offer interest rates on five-year fixed deposits above 7 percent. Assuming a rate of 7%, after five years, an investment of five hundred thousand rupees will yield 7,07,389 rupees, meaning an interest income of 2,07,389 rupees.

Popular